We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EXPE icon
176
Expedia Group
EXPE
$32.9B
$3.3M 0.08%
34,000
+28,000
+467% +$2.94M
2022 Q2
3 quarters
NKGN icon
177
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$3.24M 0.08%
320,103
– –
2021 Q3
6 quarters
NBIX icon
178
Neurocrine Biosciences
NBIX
$14.5B
$3.16M 0.07%
31,182
+25,242
+425% +$2.63M
2022 Q1
4 quarters
AZN icon
179
AstraZeneca
AZN
$247B
$3.14M 0.07%
22,600
+7,076
+46% +$952K
2022 Q1
4 quarters
SPGI icon
180
S&P Global
SPGI
$120B
$3.1M 0.07%
+9,000
New +$3.17M
2023 Q1
0 quarters
PYPL icon
181
PayPal
PYPL
$47.5B
$3.02M 0.07%
+39,770
New +$3.06M
2023 Q1
0 quarters
LVAC
182
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
$2.96M 0.07%
283,573
– –
2022 Q1
4 quarters
DMYS
183
DELISTED
dMY Technology Group, Inc. VI
DMYS
$2.94M 0.07%
287,620
-404,961
-58% -$4.11M
2021 Q4
5 quarters
APCA icon
184
DELISTED
AP Acquisition Corp
APCA
$2.93M 0.07%
278,023
– –
2022 Q1
4 quarters
APXI icon
185
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$2.93M 0.07%
278,023
– –
2022 Q1
4 quarters
EXR icon
186
Extra Space Storage
EXR
$28.4B
$2.91M 0.07%
17,886
+8,305
+87% +$1.31M
2021 Q1
8 quarters
STET
187
DELISTED
ST Energy Transition I Ltd.
STET
$2.9M 0.07%
278,023
– –
2022 Q1
4 quarters
UDR icon
188
UDR
UDR
$11B
$2.89M 0.07%
70,500
+14,692
+26% +$607K
2022 Q4
1 quarter
HMA
189
DELISTED
Heartland Media Acquisition Corp.
HMA
$2.89M 0.07%
278,023
– –
2022 Q1
4 quarters
SPCM icon
190
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$2.88M 0.07%
273,069
– –
2022 Q2
3 quarters
TGR
191
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
$2.88M 0.07%
273,069
– –
2022 Q2
3 quarters
BZAI icon
192
Blaize Holdings
BZAI
$42.6M
$2.83M 0.07%
278,023
– –
2022 Q1
4 quarters
UTHR icon
193
United Therapeutics
UTHR
$23.6B
$2.82M 0.07%
12,573
+1,051
+9% +$259K
2022 Q1
4 quarters
SLAM icon
194
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.8M 0.07%
270,951
– –
2021 Q2
7 quarters
AXTA icon
195
Axalta
AXTA
$6.98B
$2.79M 0.07%
92,070
– –
2018 Q4
17 quarters
AXNX icon
196
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.78M 0.07%
51,032
-2,570
-5% -$150K
2022 Q1
4 quarters
PHYT icon
197
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$2.76M 0.07%
262,511
– –
2022 Q1
4 quarters
WELL icon
198
Welltower
WELL
$162B
$2.75M 0.07%
38,372
+14,485
+61% +$1.05M
2022 Q3
2 quarters
ZYME icon
199
Zymeworks
ZYME
$1.85B
$2.75M 0.07%
303,732
+44,464
+17% +$388K
2022 Q2
3 quarters
SBRA icon
200
Sabra Healthcare REIT
SBRA
$4.84B
$2.75M 0.07%
238,724
+145,011
+155% +$1.79M
2022 Q2
3 quarters
6 7
8
9 10

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.